Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

• Published in: Retrovirology 2023-05, Vol.20 (1), p.9-9, Article 9
• Main Authors: Colin, Philippe, Ringe, Rajesh P, Yasmeen, Anila, Ozorowski, Gabriel, Ketas, Thomas J, Lee, Wen-Hsin, Ward, Andrew B, Moore, John P, Klasse, P J
• Format: Article
• Language: English
• Subjects: Affinity; AIDS Vaccines; Analysis; Animal models; Animals; Antibodies; Antibodies, Neutralizing; Antigenic determinants; Antigenic heterogeneity; Antigenicity; Antigens; Broadly active neutralizing antibodies (bNAbs); Broadly Neutralizing Antibodies; Care and treatment; Efficacy; env Gene Products, Human Immunodeficiency Virus; Epitopes; Health aspects; HIV; HIV (Viruses); HIV Antibodies; HIV Infections; HIV-1; HIV-1 neutralization; Human immunodeficiency virus; Hypotheses; Hypothesis testing; Immunization; Infection; Infectivity; Microscopy; Molecular Conformation; Persistent fraction; Rabbits; Stoichiometry; Surface plasmon resonance; Trimers; Viral antibodies; Viral infections; Virions; Viruses
• ISSN: 1742-4690; 1742-4690
• DOI: 10.1186/s12977-023-00624-9

Neutralizing antibodies (NAbs) protect against HIV-1 acquisition in animal models and show promise in treatment of infection. They act by binding to the viral envelope glycoprotein (Env), thereby blocking its receptor interactions and fusogenic function. The potency of neutralization is largely determined by affinity. Less well explained is the persistent fraction, the plateau of remaining infectivity at the highest antibody concentrations. We observed different persistent fractions for neutralization of pseudovirus derived from two Tier-2 isolates of HIV-1, BG505 (Clade A) and B41 (Clade B): it was pronounced for B41 but not BG505 neutralization by NAb PGT151, directed to the interface between the outer and transmembrane subunits of Env, and negligible for either virus by NAb PGT145 to an apical epitope. Autologous neutralization by poly- and monoclonal NAbs from rabbits immunized with soluble native-like B41 trimer also left substantial persistent fractions. These NAbs largely target a cluster of epitopes lining a hole in the dense glycan shield of Env around residue 289. We partially depleted B41-virion populations by incubating them with PGT145- or PGT151-conjugated beads. Each depletion reduced the sensitivity to the depleting NAb and enhanced it to the other. Autologous neutralization by the rabbit NAbs was decreased for PGT145-depleted and enhanced for PGT151-depleted B41 pseudovirus. Those changes in sensitivity encompassed both potency and the persistent fraction. We then compared soluble native-like BG505 and B41 Env trimers affinity-purified by each of three NAbs: 2G12, PGT145, or PGT151. Surface plasmon resonance showed differences among the fractions in antigenicity, including kinetics and stoichiometry, congruently with the differential neutralization. The large persistent fraction after PGT151 neutralization of B41 was attributable to low stoichiometry, which we explained structurally by clashes that the conformational plasticity of B41 Env causes. Distinct antigenic forms even of clonal HIV-1 Env, detectable among soluble native-like trimer molecules, are distributed over virions and may profoundly mold neutralization of certain isolates by certain NAbs. Affinity purifications with some antibodies may yield immunogens that preferentially expose epitopes for broadly active NAbs, shielding less cross-reactive ones. NAbs reactive with multiple conformers will together reduce the persistent fraction after passive and active immunization.